ArticleAntimicrobial agents and chemotherapy2016
Complete Sequences of mcr-1-Harboring Plasmids from Extended-Spectrum-β-Lactamase- and Carbapenemase-Producing Enterobacteriaceae.
Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
80 citing papers in PubMed, 134 citations in OpenAlex.
- First Detection of theAntibiotics (Basel, Switzerland) · 2026Article
- Epidemiology, genetic dynamics, and transmission of theEmerging microbes & infections · 2025Article
- Investigation of Antibiotic Resistance ofMicroorganisms · 2024Article
- The HicAB System: Characteristics and Biological Roles of an Underappreciated Toxin-Antitoxin System.International journal of molecular sciences · 2024Review
- TheJAC-antimicrobial resistance · 2024Article
- Genomic Profiling of Multidrug-Resistant SwineAntibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial Resistance Profiles of Multidrug-Resistant Enterobacteria Isolated from Feces of Weaned Piglets.Current microbiology · 2023Article
- Emergence and Genomic Features of aAntibiotics (Basel, Switzerland) · 2023Article
- Prevalence and Genomic Characteristics ofMicrobiology spectrum · 2023Article
- Stability and genetic insights of the co-existence ofFrontiers in public health · 2023Article
- More thanFrontiers in cellular and infection microbiology · 2023Article
- Genetic characteristic of coexisting ofFrontiers in microbiology · 2023Article
- NDM-5-ProducingAnimals : an open access journal from MDPI · 2022Article
- Characteristics of the plasmid-mediated colistin-resistance geneFrontiers in microbiology · 2022Article
- ISmSystems · 2021Article
- A Large Spatial Survey of Colistin-Resistant GeneMicroorganisms · 2021Article
- Genomic Features of MCR-1 and Extended-Spectrum β-Lactamase-Producing Enterobacterales from Retail Raw Chicken in Egypt.Microorganisms · 2021Article
- Plasmid MediatedFrontiers in microbiology · 2021Article
- Article
- Occurrence and Molecular Characteristics ofAnimals : an open access journal from MDPI · 2020Article
20 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 2 countries.
Funding
Abstract
Here we completely sequenced four mcr-1-haboring plasmids, isolated from two extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli and two carbapenemase-producing Klebsiella pneumoniae clinical isolates. The mcr-1-harboring plasmids from an E. coli sequence type 2448 (ST2448) isolate and two K. pneumoniae ST25 isolates were identical (all pMCR1-IncX4), belonging to the IncX4 incompatibility group, while the plasmid from an E. coli ST2085 isolate (pMCR1-IncI2) belongs to the IncI2 group. A nearly identical 2.6-kb mcr-1-pap2 element was found to be shared by all mcr-1-carrying plasmids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.